Sanara MedTech, Inc. (SMTI)
34.34
-0.11
(-0.32%)
USD |
NASDAQ |
Aug 24, 16:00
34.34
0.00 (0.00%)
After-Hours: 20:00
Sanara MedTech Price to Book Value : 39.74 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 39.87 |
| August 20, 2026 | 39.63 |
| August 19, 2026 | 39.67 |
| August 18, 2026 | 39.55 |
| August 17, 2026 | 39.35 |
| August 14, 2026 | 39.52 |
| August 13, 2026 | 39.54 |
| August 12, 2026 | 39.73 |
| August 11, 2026 | 39.79 |
| August 10, 2026 | 39.64 |
| August 07, 2026 | 39.47 |
| August 06, 2026 | 39.45 |
| August 05, 2026 | 39.43 |
| August 04, 2026 | 39.42 |
| August 03, 2026 | 39.35 |
| July 31, 2026 | 39.19 |
| July 30, 2026 | 39.42 |
| July 29, 2026 | 35.01 |
| July 28, 2026 | 30.83 |
| July 27, 2026 | 29.92 |
| July 24, 2026 | 29.58 |
| July 23, 2026 | 29.51 |
| July 22, 2026 | 29.56 |
| July 21, 2026 | 29.51 |
| July 20, 2026 | 28.93 |
| Date | Value |
|---|---|
| July 17, 2026 | 28.93 |
| July 16, 2026 | 29.30 |
| July 15, 2026 | 28.38 |
| July 14, 2026 | 27.14 |
| July 13, 2026 | 28.84 |
| July 10, 2026 | 27.57 |
| July 09, 2026 | 27.64 |
| July 08, 2026 | 28.04 |
| July 07, 2026 | 28.69 |
| July 06, 2026 | 29.13 |
| July 02, 2026 | 28.75 |
| July 01, 2026 | 28.09 |
| June 30, 2026 | 27.30 |
| June 29, 2026 | 32.05 |
| June 26, 2026 | 31.14 |
| June 25, 2026 | 30.15 |
| June 24, 2026 | 29.85 |
| June 23, 2026 | 28.36 |
| June 22, 2026 | 28.36 |
| June 18, 2026 | 28.71 |
| June 17, 2026 | 27.67 |
| June 16, 2026 | 29.59 |
| June 15, 2026 | 28.54 |
| June 12, 2026 | 27.14 |
| June 11, 2026 | 28.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intelligent Bio Solutions, Inc. | 1.323 |
| Anteris Technologies Global Corp. | 3.408 |
| 20/20 Biolabs, Inc. | 3.885 |
| Quest Diagnostics, Inc. | 3.569 |
| Labcorp Holdings, Inc. | 3.192 |
Price to Book Value Related Metrics
| PS Ratio | 2.718 |
| PEG Ratio | -0.0423 |
| Price to Free Cash Flow | 66.27 |
| Price | 34.34 |
| Earnings Yield | -10.80% |
| Market Cap | 315.70M |
| PEGY Ratio | -0.0423 |
| Operating PE Ratio | 26.19 |